Giants of Cancer Care® Announces Ninth Annual Class of Inductees

OncLive®, the nation's leading multimedia resource for oncology professionals, and Pfizer, its platinum sponsor, are pleased to announce the finalists of the ninth annual Giants of Cancer Care® program.

OncLive®, the nation's leading multimedia resource for oncology professionals, and Pfizer, its platinum sponsor, are pleased to announce the finalists of the ninth annual Giants of Cancer Care® program.

Since 2013, the program has celebrated more than 125 oncology legends for their groundbreaking achievements in oncology research and clinical practice. Out of hundreds of nominations, only 14 oncologists were selected to join the prestigious 2021 class.

The Giants of Cancer Care® Steering Committee selects semifinalists from nominations submitted each year and the Selection Committee—comprised of more than 120 eminent oncologists, clinicians, and researchers—then votes on the finalists in each category.

"We'd like to congratulate each and every member of this year's class of inductees on this enormous honor," said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of OncLive®. "It is no surprise that these oncologists were recognized for their contributions and dedication to this vital practice. They are all pioneers within the global field of oncology."

This year's inductees by award category are as follows:

Breast Cancer- Nancy E. Davidson, MD, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Community Outreach/Cancer Policy- Julie Gralow, MD, American Society of Clinical Oncology
  • Gastrointestinal Cancer- Daniel G. Haller, MD Abramson Cancer Center at the University of Pennsylvania Perelman School of Medicine
  • Genitourinary Cancer- Toni Choueiri, MD, Dana-Farber Cancer Institute/Brigham and Women's Hospital
  • Gynecologic Cancer- Robert Young, MD, RCY Medicine
  • Leukemia- Richard M. Stone, MD, Dana-Farber Cancer Institute
  • Lung Cancer- Pasi A. Jänne, MD, PhD, Dana-Farber Cancer Institute
  • Lymphoma- Steven T. Rosen, MD, City of Hope Comprehensive Cancer Center
  • Melanoma- Michael B. Atkins, MD, Georgetown Lombardi Comprehensive Cancer Center
  • Myeloma- Paul G. Richardson, MD, Dana-Farber Cancer Institute/Jerome Lipper Multiple Myeloma Center
  • Pediatric Oncology- Richard J. O'Reilly, MD, Memorial Sloan Kettering Cancer Center
  • Prevention/Genetics- Matthew L. Meyerson, MD, PhD, Dana-Farber Cancer Institute
  • Radiation Oncology- Walter J. Curran Jr, MD, GenesisCare/Emory University School of Medicine
  • Supportive, Palliative, and/or Geriatric Care - Dawn L. Hershman, MD, MS, Herbert Irving Comprehensive Cancer Center at Columbia University

The hybrid award ceremony will take place on Thursday, November 4, 2021 at 6:30 p.m. at the Marriott Marquis in NYC. For more information on registration, click here.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive® is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels. 

About Giants of Cancer Care®

Giants of Cancer Care® celebrates the achievements of leading researchers and educators whose discoveries have helped propel the field of oncology and established the building blocks for future advances. Every year, a selection committee of more than 120 eminent oncologists, researchers and clinicians chooses honorees from several types of tumor and specialty categories.